FTC Probes Epic Systems Over Noncompetes and Data Access Barriers in EHR Market

The FTC inquiry, still in early stages, draws on interviews with health IT executives who described questions about Epic's noncompete clauses that bar staff from joining competitors or even indirectly related firms. Separate lines of questioning target how Epic uses its 36 percent share of U.S. hospital EHR installations to condition data sharing on terms that disadvantage third-party developers. These practices echo prior lawsuits from Cerner and others alleging deliberate interoperability friction.

Epic's dominance stems from its 2009-2021 growth via meaningful-use incentives and hospital consolidation, creating a de facto standard that now controls records for roughly 250 million Americans. Observational data from CMS interoperability reports show persistent gaps in real-time data exchange for non-Epic users, correlating with slower adoption of AI tools for care coordination. This structure raises questions about whether market position, rather than technical merit, determines which innovations reach patients.

The probe connects to broader health-data policy failures, including delayed implementation of the 21st Century Cures Act information-blocking rules. Unlike pharmaceutical antitrust cases focused on pricing, here the harm centers on suppressed competition in analytics and decision support that could improve outcomes. Regulators have not yet indicated whether conduct meets Sherman Act thresholds for willful maintenance of monopoly power.

Next steps likely include document requests to hospital customers and analysis of Epic's internal strategy memos. Any enforcement action would require demonstrating consumer harm beyond competitor complaints, a higher bar than the current preliminary contacts suggest.